Thyrotoxic periodic paralysis presenting as acute quadriparesis in a middle-aged male: a case report

Authors

  • Amarnath Duraikannan Department of Endocrinology, Diabetes and Internal Medicine, EMC Group of Hospitals, Green Avenue, Amritsar, Punjab, India
  • Pankaj Soni Department of Critical Care and ICU, EMC Group of Hospitals, Green Avenue, Amritsar, Punjab, India
  • Monikeerthana Anandhasekar Department of Psychiatry, EMC Group of Hospitals, Green Avenue, Amritsar, Punjab, India
  • Rishab Arora Department of Endocrinology, Diabetes and Internal Medicine, EMC Group of Hospitals, Green Avenue, Amritsar, Punjab, India
  • Manwinder Kaur Emergency Department, EMC Group of Hospitals, Green Avenue, Amritsar, Punjab, India
  • Shaifali Sinha Department of Endocrinology, Diabetes and Internal Medicine, EMC Group of Hospitals, Green Avenue, Amritsar, Punjab, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20253309

Keywords:

Acute paralysis, Graves’ disease, Hypokalaemia, Thyrotoxic periodic paralysis

Abstract

Thyrotoxic periodic paralysis (TPP) is a rare, potentially life-threatening complication of hyperthyroidism characterised by acute flaccid paralysis due to hypokalaemia. We report the case of a 46-year-old man who presented with sudden-onset generalised weakness that progressed to quadriparesis over a few hours. Laboratory investigations revealed severe hypokalaemia (2.6 mmol/l) and thyrotoxicosis (FT3 8.76 pmol/l, FT4 32.71 pmol/l, TSH 0.01 µIU/ml), with elevated thyrotropin receptor antibody (TRAb 12.2 IU/l). Ultrasound revealed diffuse thyroid enlargement with increased vascularity. The patient received intravenous potassium supplementation, propranolol, and carbimazole and completely recovered within 24 hours. He was advised to avoid precipitating factors such as high-carbohydrate meals, alcohol, and strenuous activity, and was referred for definitive management of hyperthyroidism. This case highlights the importance of considering TPP in Asian males presenting with acute flaccid paralysis and hypokalaemia. Early recognition, cautious potassium replacement, and timely initiation of antithyroid therapy are essential to prevent serious complications and ensure complete recovery.

Metrics

Metrics Loading ...

References

Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc. 2005;80(1):99-105. DOI: https://doi.org/10.4065/80.1.99

Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. Hyperinsulinaemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis. Clin Endocrinol (Oxf). 1994;41(1):213-6. DOI: https://doi.org/10.1111/j.1365-2265.1994.tb02532.x

Bayrak Demirel O, Koc C, Tercan U, Abali S, Kardelen AD, Yildiz M, et al. Thyrotoxic hypokalemic periodic paralysis induced by high-dose insulin in an adolescent male with type 1 diabetes mellitus. Horm Res Paediatr. 2024;1-5. DOI: https://doi.org/10.1159/000543329

Kung AWC. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006;91(7):2490-5. DOI: https://doi.org/10.1210/jc.2006-0356

Vijayakumar A, Ashwath G, Thimmappa D. Thyrotoxic periodic paralysis: clinical challenges. J Thyroid Res. 2014;2014:649502. DOI: https://doi.org/10.1155/2014/649502

Barahona MJ, Vinagre I, Sojo L, Cubero JM, Pérez A. Thyrotoxic periodic paralysis: a case report and literature review. Clin Med Res. 2009;7(3):96-8. DOI: https://doi.org/10.3121/cmr.2009.816

Hsieh CH, Kuo SW, Pei D, Hung YJ, ChyiFan S, Wu LI, et al. Thyrotoxic periodic paralysis: an overview. Ann Saudi Med. 2004;24(6):418-22. DOI: https://doi.org/10.5144/0256-4947.2004.418

Atrash J, Musleh T, Naji Y, Said V, Saraheen M. Thyrotoxic periodic paralysis: A unique case highlighting the diagnostic challenges and management. Cureus. 2024;16(11):e73275. DOI: https://doi.org/10.7759/cureus.73275

Verma V, Kumar Y, Kotwal N, Upreti V, Hari Kumar KVS, Singh Y, et al. Thyrotoxic periodic paralysis: A retrospective, observational study from India: A retrospective, observational study from India. Indian J Med Res. 2020;151(1):42-6. DOI: https://doi.org/10.4103/ijmr.IJMR_335_18

Paul J, Joseph A, Jebasingh F, More AR, Hephzibah J, Cherian KE, et al. Thyrotoxic periodic paralysis-a retrospective study from Southern India. Eur Thyroid J. 2024;13(6):e240164. DOI: https://doi.org/10.1530/ETJ-24-0164

Lam L, Nair RJ, Tingle L. Thyrotoxic periodic paralysis. Proc (Bayl Univ Med Cent). 2006;19(2):126-9. DOI: https://doi.org/10.1080/08998280.2006.11928143

Karndumri K, Thewjitcharoen Y, Chatchomchuan W, Porramatikul S, Krittiyawong S, Wanothayaroj E, et al. Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves’ disease patients with thyrotoxic periodic paralysis. J Clin Transl Endocrinol. 2020;21:100235. DOI: https://doi.org/10.1016/j.jcte.2020.100235

Cid Puente R, Aguirre Moreno PD, Barrios Muñoz AM, Garcia Luis AM, Contreras Saenz CP. Unveiling thyrotoxic periodic paralysis: A rare hyperthyroid complication. Cureus. 2025;17(4):e83280. DOI: https://doi.org/10.7759/cureus.83280

Downloads

Published

2025-10-09

How to Cite

Duraikannan, A., Soni, P., Anandhasekar, M., Arora, R., Kaur, M., & Sinha, S. (2025). Thyrotoxic periodic paralysis presenting as acute quadriparesis in a middle-aged male: a case report. International Journal of Research in Medical Sciences, 13(11), 4950–4952. https://doi.org/10.18203/2320-6012.ijrms20253309

Issue

Section

Case Reports